Depression, anxiety and poor QOL in women with ovarian cancer

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.286, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL benefits with palliative chemotherapy in ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

QOL better with carboplatin + paclitaxel for ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 498, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Fluoxetine affords QOL benefit in advanced cancer, depression

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Anti-idiotype ovarian cancer vaccine CA-125 can delay relapse and improve measures of QOL

Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite